January 23, 2014
View Full PaperGRIA2 is a novel diagnostic marker for solitary fibrous tumour identified through gene expression profiling
Key Points
Key points are not available for this paper at this time.
Abstract
GRIA2 is a useful marker for distinguishing SFT from most mimics. Among other CD34-positive tumours, GRIA2 is also expressed in DFSP; however, clinical and histological features aid in their distinction. GRIA2 shows a limited distribution in other soft tissue tumours.